S
BEAT

SignatureFD’s BioTelemetry, Inc. BEAT Stock Holding History

SignatureFD’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27
Closed -$2K – 2889
2020
Q4 		$2K Sell
27
-18
-40% -$942 ﹤0.01% 2362
2020
Q3 		$2K Hold
45
– – ﹤0.01% 2340
2020
Q2 		$2K Hold
45
– – ﹤0.01% 2246
2020
Q1 		$2K Sell
45
-34
-43% -$1.56K ﹤0.01% 2049
2019
Q4 		$4K Buy
79
+51
+182% +$2.21K ﹤0.01% 1739
2019
Q3 		$1K Buy
28
+18
+180% +$777 ﹤0.01% 2078
2019
Q2 		$0 Sell
10
-10
-50% -$526 ﹤0.01% 2254
2019
Q1 		$1K Sell
20
-13
-39% -$893 ﹤0.01% 1951
2018
Q4 		$2K Buy
33
+5
+18% +$300 ﹤0.01% 1783
2018
Q3 		$2K Sell
28
-12
-30% -$670 ﹤0.01% 1753
2018
Q2 		$2K Sell
40
-3
-7% -$120 ﹤0.01% 1774
2018
Q1 		$1K Buy
+43
New +$1.41K ﹤0.01% 1727

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

SignatureFD's BEAT Position: Q1 2021 in Review

SignatureFD sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 27 shares — an estimated $2K sold.

SignatureFD first reported a position in BEAT in Q1 2018 and held it in 12 quarters. The position peaked at $4K in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • SignatureFD reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • SignatureFD sold 27 BioTelemetry, Inc. shares in Q1 2021, an estimated $2K.
  • SignatureFD first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 12 quarters.
  • SignatureFD's BioTelemetry, Inc. position peaked at $4K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on SignatureFD's 13F filing for Q1 2021, filed 30 Apr 2021.